Project Grant HT94252310348
Award Date
9/1/23
Completion Date
8/31/26
Dollars Obligated
$980K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Hershey, PA 17033, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency has awarded a $1,255,505 Project Grant to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, under the Military Medical Research and Development program (CFDA 12.420). The grant, which has a performance period of July 1, 2024 to June 30, 2027, is for the development of a unique small molecule for the treatment of triple-negative breast cancer. As a leading academic medical center, Penn State has...
The Trustees of the University of Pennsylvania will receive $975,000 through a three-year Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support lung cancer research from July 1, 2023 to June 30, 2026. Through this funding, the University and its Clinical Practices will conduct biomedical research to transform service member healthcare and investigate medical solutions applicable to battlefield medicine....
This federal Project Grant award of $384,063.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research conducted by The Pennsylvania State University (Penn State) to investigate the direct genetic modification of Plasmodium sporozoites using mRNA/lipid nanoparticles. The research aims to transform healthcare for military service members and the broader public by advancing innovative biomedical solutions. The project...
Pennsylvania State University College of Medicine received a $162,180 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) for the period of September 1, 2021 through August 31, 2022. The grant funds research to investigate the role of the Notch pathway in promoting the adaptation of metastatic lung cancer cells to the brain microenvironment. The Military Medical Research and Development program supports...
The Pennsylvania State University was awarded a $990,405 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award will support the development of dual-modality ultrasound and photoacoustic molecular imaging strategies for aggressive prostate cancer detection. Penn State will collaborate with Case Western Reserve University on investigating medical solutions for detecting lethal prostate cancer...
The Pennsylvania State University College of Medicine was awarded a $810,901 Project Grant from the Department of the Army Medical Command on September 15, 2021 to complete work by September 14, 2024. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative solutions for battlefield medicine. Under this award, Penn State will investigate...
This federal Project Grant award in the amount of $1,605,638.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant was awarded to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, a private research university and academic medical center. The grant funding supports research aimed at developing new methods for immune targeting of dormant tumor...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $829,986.00 Project Grant to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, to conduct research titled "Identifying Novel Approaches for Melanoma Prevention Using Mouse Models with Humanized Telomeres". This 3-year grant, effective September 30, 2023, aims to advance innovative biomedical research into melanoma prevention...
The U.S. Defense Health Agency awarded a $831,658 Project Grant to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project investigating "GUT-BRAIN MECHANISMS OF IMPROVING HEALTH IN AN ANIMAL MODEL OF SCI FOLLOWING WEIGHT LOSS SURGERY". As a leading academic medical center, Penn State has a track record of delivering...
This $390,000 Formula Grant was awarded on March 15, 2025 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research by The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, to define oncogenic signaling networks and establish novel targets for lung adenocarcinoma therapy. The research aims to exploit synthetic essential genetic dependencies...